Pioglitazone Tablet
Product Images NDC 68788-7514

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68788-7514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

The text describes a figure in a 26-week study that shows the mean change from baseline for HbAlc in a dose-ranging experiment. The experiment was placebo-controlled and the figure shows the observed values. The X-axis shows the duration of the study in weeks, while the Y-axis shows the mean change from baseline for HbAlc. The figure displays three dosage levels (15mg, 30mg, 45mg) and illustrates how the HbAlc changes from baseline.*

FDA Label Image

Pioglitazone Tablets 30mg (Pioglitazone Fig3)

FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.